London Hydrogel Injections For Knee Arthritis Pain: Effective Treatment Launched

MSK Doctors (03-300-010-048) in London is now offering hydrogel injections to patients who are suffering from arthritis pain in their knees.

The Founder of MSK Doctors, Professor Paul Lee MBBch, MRCS, MFSEM (UK), MSc (Sports Med), PhD, FEBOT, FRCS (Tr & Orth), is pleased to now be treating patients who have knee arthritis with Arthrosamid, which is also known as Polyacrylamide (PAAG) hydrogel. This synthetic hydrogel is an effective new alternative to hyaluronic acid that has shown significant promise in patient trials.

More information is available at https://mskdoctors.com/treatments/arthrosamid

While the specialised surgical team at MSK Doctors can offer their patients full knee replacement or arthroplasty surgeries, which are often required in cases of severe knee osteoarthritis, they prefer less invasive interventions where possible, and they believe that Arthrosamid offers significant benefits for many patients.

As a spokesperson for the clinic explained, this synthetic hydrogel, when injected into the knee joint, adheres itself to the synovial membrane. That is, to the thin layer of connective tissue that lines one's knee joint, protecting it and allowing it to move smoothly. Compellingly, once it has been adhered to this membrane, it has been shown to not only reinforce it but to encourage its natural regeneration.

As MSK Doctors’ spokesperson said, “Arthrosamid presents a promising and innovative treatment option for knee osteoarthritis. Its unique mechanism of action, involving the provision of a scaffold for the synovial membrane, offers a new avenue for tissue regeneration.”

As such, the clinic is pleased to be an early adopter of the technology, which has been positively associated with significantly reduced pain and inflammation and with improved mobility and stability—lasting, under study, for six months up to at least one year. It has also been shown to help treat connected conditions like Patellofemoral Bone Marrow Lesions.

The clinic's spokesperson added, “Clinical studies and real-world patient stories corroborate Arthrosamid’s efficacy, safety, and long-term benefits. Comparative studies have also highlighted its superior performance against traditional treatments like hyaluronic acid. With a high level of confidence supported by extensive research and patient testimonials, Arthrosamid is poised to make a significant impact in the field of orthopaedic surgery and regenerative medicine.”

About MSK Doctors

MSK Doctors is one of London’s leading regenerative and musculoskeletal medicine clinics. Founder Professor Paul Lee is well known as one of the UK’s preeminent experts in orthopaedic surgery and he is committed to enhancing the practice of effective, non-invasive treatments in the fight against arthritis and osteoarthritis.

For more information, visit https://mskdoctors.com/

The Founder of MSK Doctors, Professor Paul Lee MBBch, MRCS, MFSEM (UK), MSc (Sports Med), PhD, FEBOT, FRCS (Tr & Orth), is pleased to now be treating patients who have knee arthritis with Arthrosamid, which is also known as Polyacrylamide (PAAG) hydrogel. This synthetic hydrogel is an effective new alternative to hyaluronic acid that has shown significant promise in patient trials.

More information is available at https://mskdoctors.com/treatments/arthrosamid

While the specialised surgical team at MSK Doctors can offer their patients full knee replacement or arthroplasty surgeries, which are often required in cases of severe knee osteoarthritis, they prefer less invasive interventions where possible, and they believe that Arthrosamid offers significant benefits for many patients.

As a spokesperson for the clinic explained, this synthetic hydrogel, when injected into the knee joint, adheres itself to the synovial membrane. That is, to the thin layer of connective tissue that lines one's knee joint, protecting it and allowing it to move smoothly. Compellingly, once it has been adhered to this membrane, it has been shown to not only reinforce it but to encourage its natural regeneration.

As MSK Doctors’ spokesperson said, “Arthrosamid presents a promising and innovative treatment option for knee osteoarthritis. Its unique mechanism of action, involving the provision of a scaffold for the synovial membrane, offers a new avenue for tissue regeneration.”

As such, the clinic is pleased to be an early adopter of the technology, which has been positively associated with significantly reduced pain and inflammation and with improved mobility and stability—lasting, under study, for six months up to at least one year. It has also been shown to help treat connected conditions like Patellofemoral Bone Marrow Lesions.

The clinic's spokesperson added, “Clinical studies and real-world patient stories corroborate Arthrosamid’s efficacy, safety, and long-term benefits. Comparative studies have also highlighted its superior performance against traditional treatments like hyaluronic acid. With a high level of confidence supported by extensive research and patient testimonials, Arthrosamid is poised to make a significant impact in the field of orthopaedic surgery and regenerative medicine.”

About MSK Doctors

MSK Doctors is one of London’s leading regenerative and musculoskeletal medicine clinics. Founder Professor Paul Lee is well known as one of the UK’s preeminent experts in orthopaedic surgery and he is committed to enhancing the practice of effective, non-invasive treatments in the fight against arthritis and osteoarthritis.

For more information, visit https://mskdoctors.com/

Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com

Source: PressCable

Release ID: 89148887

In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.